Skip to content

What is the new shot for menopause?: Understanding the Latest Treatment

3 min read

Over 80% of women experience hot flashes during menopause, a symptom that can significantly disrupt daily life. Many are now asking, What is the new shot for menopause?, prompted by news of recent treatment advances. However, this popular search term points to a common misconception about the form of the latest breakthrough therapy.

Quick Summary

While there is no new shot for menopause, a significant advancement is Veozah (fezolinetant), a daily non-hormonal pill for moderate to severe hot flashes and night sweats, approved by the FDA in May 2023.

Key Points

  • Veozah is a pill, not a shot: The widely discussed new treatment for menopausal hot flashes is a daily oral tablet called Veozah (fezolinetant), not an injection.

  • Non-hormonal mechanism: Veozah works by blocking a chemical in the brain (NKB) that helps regulate body temperature, offering a safe option for women who cannot use hormone replacement therapy (HRT).

  • Requires liver monitoring: Due to a rare risk of serious liver injury, patients taking Veozah must undergo regular blood tests to check their liver function.

  • Alternative non-hormonal options: Other treatments for hot flashes include the emerging pill Elinzanetant, certain antidepressants, gabapentin, and lifestyle changes.

  • Personalized treatment is key: The best approach for managing menopause symptoms depends on individual health factors, making a consultation with a healthcare provider essential.

  • HRT is still an option for many: Traditional hormone replacement therapy remains an effective treatment for hot flashes and other symptoms, but carries different risks than non-hormonal alternatives.

In This Article

The “Shot” Misconception: Clarifying the New Treatment

While some older hormone replacement therapies (HRT) were available as injections, the most talked-about recent treatment is a pill, not an injection. The interest in a "new shot" likely stems from the excitement surrounding novel, non-hormonal options for managing menopausal hot flashes and night sweats, also known as vasomotor symptoms (VMS).

Veozah (Fezolinetant): The Pill Breakthrough for Hot Flashes

Veozah (fezolinetant) is a new non-hormonal medication approved by the FDA in May 2023 for treating moderate to severe menopausal hot flashes. It offers an alternative for women who cannot use or prefer to avoid hormonal treatments. Instead of replacing hormones, Veozah targets the underlying cause of hot flashes in the brain.

How Veozah Works

During menopause, decreased estrogen can lead to overactive KNDy neurons in the hypothalamus, which control temperature. Veozah blocks a brain chemical (neurokinin B or NKB) from binding to its receptor on these neurons. This action helps regulate the body's temperature control system, reducing hot flashes and night sweats.

Veozah vs. Hormone Replacement Therapy (HRT)

HRT has been a standard treatment for menopausal symptoms but isn't suitable for everyone, particularly those with certain medical histories.

Key differences include:

  • Mechanism: HRT replaces hormones, while Veozah blocks a specific brain chemical.
  • Target Symptoms: Veozah is specifically for moderate to severe hot flashes and night sweats, whereas HRT can address a broader range of menopausal symptoms.
  • Suitability: Veozah is often an option for women who cannot use HRT.

Potential Side Effects and Safety Considerations

Common side effects of Veozah include abdominal pain, diarrhea, and insomnia. There is also a rare but serious risk of liver injury. Liver function tests are required before starting and periodically during treatment. The medication should be stopped if liver function becomes significantly elevated.

Other Emerging Non-Hormonal Options

In addition to Veozah, other non-hormonal treatments are available or in development:

  • Elinzanetant: Another neurokinin receptor antagonist showing promise in reducing hot flashes and improving sleep.
  • Lifestyle Interventions: Diet, exercise, and stress reduction can help manage symptoms.
  • Acupuncture: Some studies suggest it may help with hot flashes, especially for those avoiding HRT.

Comparison of Treatment Options for Menopausal Symptoms

Treatment Option Mechanism Primary Symptoms Addressed Pros Cons
Veozah (fezolinetant) Non-hormonal NK3 receptor antagonist; blocks NKB in the brain's thermoregulatory center. Moderate to severe hot flashes and night sweats. Non-hormonal, rapid relief for some, suitable for women who can't take HRT. Potential for liver injury, requires blood tests, common side effects like abdominal pain.
Hormone Replacement Therapy (HRT) Replaces declining estrogen levels in the body. Hot flashes, vaginal dryness, bone density loss. Highly effective for a wide range of symptoms, can also prevent bone loss. Not suitable for all women, associated risks of breast cancer and blood clots.
Elinzanetant Dual neurokinin 1 and 3 receptor antagonist. Hot flashes and night sweats. Shows promise in improving sleep and quality of life in clinical trials. Still in development with regulatory applications pending.
SSRIs/SNRIs Non-hormonal antidepressants that can reduce hot flashes. Hot flashes, mood changes. Non-hormonal, can also help with mood symptoms. May have side effects like nausea or sexual dysfunction.
Gabapentin Nerve pain medication that can reduce hot flashes. Hot flashes. Non-hormonal, can also help with sleep. May cause drowsiness or dizziness.
Lifestyle Modifications Regular exercise, managing stress, dietary changes. Mild symptoms, overall well-being. No pharmaceutical side effects, supports overall health. May not be sufficient for moderate to severe symptoms.

The Importance of Consulting Your Healthcare Provider

Discussing menopause symptoms and treatment options with a healthcare professional is essential to determine the best approach for your individual needs and medical history.

Conclusion: Understanding Your Options for Menopause Relief

While there isn't a new "shot" for menopause, Veozah (fezolinetant) represents a significant non-hormonal advancement for managing hot flashes. Understanding this and other treatment options allows for informed discussions with your doctor to find suitable relief and improve your quality of life. For further information, consult resources like the U.S. Food and Drug Administration (FDA) website for drug safety communications.

Frequently Asked Questions

No, there is no new shot for menopause. The newest treatment is a non-hormonal pill, Veozah (fezolinetant). Traditional HRT involves replacing hormones and is different from Veozah's targeted, non-hormonal approach.

The confusion likely stems from the novelty of new non-hormonal therapies and the fact that some older HRT treatments were available as injections. Veozah's approval in 2023 brought significant attention to modern menopausal treatments, but it is an oral tablet.

Veozah is a non-hormonal, oral medication approved by the FDA to treat moderate to severe vasomotor symptoms (hot flashes and night sweats) caused by menopause. It blocks specific receptors in the brain to help regulate body temperature.

Unlike some antidepressants or gabapentin, Veozah specifically targets the neurochemical pathway (NKB) in the brain that controls body temperature, providing a more direct mechanism for reducing hot flashes. Its effectiveness has been demonstrated in clinical trials.

Yes, common side effects can include stomach pain, diarrhea, and insomnia. The FDA has also added a boxed warning about a rare but serious risk of liver injury, which requires blood monitoring before and during treatment.

Veozah was developed as a non-hormonal alternative specifically for women who are not candidates for or choose not to use hormone replacement therapy, such as those with certain medical conditions.

No, Elinzanetant is another emerging non-hormonal pill, currently in regulatory review with the FDA, that also aims to reduce hot flashes and improve sleep. It is not an injection.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.